Also, higher serum or plasma VEGF levels predict clinicopathologic features of HCC, including increased tumor size, presence of distant metastases and/or vascular invasion, and advanced stage [12-14]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.